Viridian Therapeutics, Inc.\DE (VRDN) Other Accumulated Expenses (2013 - 2016)

Viridian Therapeutics, Inc.\DE's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $4000.0 for Q4 2016.

• In Q4 2016, Other Accumulated Expenses fell 95.24% year-over-year to $4000.0; the TTM figure through Dec 2016 stood at $4000.0 (down 95.24% YoY), while the FY2016 annual figure was $4000.0, down 95.24% from the prior year.
• Other Accumulated Expenses for Q4 2016 stood at $4000.0, down from $228000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $228000.0 in Q3 2016, with the low at $4000.0 in Q4 2016.
• The 4-year median for Other Accumulated Expenses is $64500.0 (2014), against an average of $78263.2.
• Peak annual rise in Other Accumulated Expenses reached 125.74% in 2016, while the deepest fall reached 95.24% in 2016.
• Viridian Therapeutics, Inc.\DE's Other Accumulated Expenses stood at $40000.0 in 2013, then jumped by 55.0% to $62000.0 in 2014, then soared by 35.48% to $84000.0 in 2015, then slumped by 95.24% to $4000.0 in 2016.
• Business Quant data shows VRDN's Other Accumulated Expenses at $4000.0 in Q4 2016, $228000.0 in Q3 2016, and $67000.0 in Q2 2016.